Correction to: Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signaling.

Yang, Na; Zou, Chunpeng; Luo, Wu; Xu, Diyun; Wang, Mengyang; Wang, Yi; Wu, Gaojun; Shan, Peiren; Liang, Guang.

Affiliation

Yang N; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Zou C; Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Luo W; Department of Ultrasonography, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xu D; Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wang M; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Wang Y; Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wu G; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Shan P; Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, Yanbian University, Yanji, China.
Liang G; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.

Phytother Res ; 38(3): 1715-1716, 2024 Mar.

Article in En | MEDLINE | ID: mdl-38317321

Full text: 1 Database: MEDLINE Language: En Journal: Phytother Res Year: 2024 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Language: En Journal: Phytother Res Year: 2024 Type: Article Affiliation country: China